137 related articles for article (PubMed ID: 24347431)
1. Use of the mouse ear vesicant model to evaluate the effectiveness of ebselen as a countermeasure to the nitrogen mustard mechlorethamine.
Lulla A; Reznik S; Trombetta L; Billack B
J Appl Toxicol; 2014 Dec; 34(12):1373-8. PubMed ID: 24347431
[TBL] [Abstract][Full Text] [Related]
2. Ebselen oxide attenuates mechlorethamine dermatotoxicity in the mouse ear vesicant model.
Tumu HCR; Cuffari BJ; Pino MA; Palus J; Piętka-Ottlik M; Billack B
Drug Chem Toxicol; 2020 Jul; 43(4):335-346. PubMed ID: 30257109
[TBL] [Abstract][Full Text] [Related]
3. Combination of ebselen and hydrocortisone substantially reduces nitrogen mustard-induced cutaneous injury.
Tumu HCR; Cuffari BJ; Billack B
Curr Res Toxicol; 2021; 2():375-385. PubMed ID: 34806038
[TBL] [Abstract][Full Text] [Related]
4. Selected ebselen analogs reduce mechlorethamine toxicity in vitro.
Pino MA; Pietka-Ottlik M; Billack B
Cutan Ocul Toxicol; 2014 Mar; 33(1):32-41. PubMed ID: 23734969
[TBL] [Abstract][Full Text] [Related]
5. Ebselen reduces the toxicity of mechlorethamine in A-431 cells via inhibition of apoptosis.
Lulla A; Pino MA; Piętka-Ottlik M; Młochowski J; Sparavalo O; Billack B
J Biochem Mol Toxicol; 2013 Jun; 27(6):313-22. PubMed ID: 23649643
[TBL] [Abstract][Full Text] [Related]
6. Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity.
Hardej D; Billack B
Toxicol Ind Health; 2007 May; 23(4):209-21. PubMed ID: 18429381
[TBL] [Abstract][Full Text] [Related]
7. Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells.
Pino MA; Billack B
Cutan Ocul Toxicol; 2008; 27(3):161-72. PubMed ID: 18988086
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the time-dependent dermatotoxicity of mechlorethamine using the mouse ear vesicant model.
Cuffari BJ; Tumu HCR; Pino MA; Billack B
Interdiscip Toxicol; 2018 Dec; 11(4):255-266. PubMed ID: 31762677
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the mTOR pathway by mechlorethamine.
Rao TJR; Mao G; Cuffari BJ; Billack B
Toxicology; 2023 Mar; 486():153434. PubMed ID: 36708981
[TBL] [Abstract][Full Text] [Related]
10. Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen.
Holl V; Coelho D; Silbernagel L; Keyser JF; Waltzinger C; Dufour P; Bischoff PL
Biochem Pharmacol; 2000 Dec; 60(11):1565-77. PubMed ID: 11077038
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse.
Dorr RT; Soble M; Alberts DS
Cancer Chemother Pharmacol; 1988; 22(4):299-302. PubMed ID: 3168143
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model.
Casillas RP; Kiser RC; Truxall JA; Singer AW; Shumaker SM; Niemuth NA; Ricketts KM; Mitcheltree LW; Castrejon LR; Blank JA
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S145-51. PubMed ID: 11428628
[TBL] [Abstract][Full Text] [Related]
13. Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity.
Wormser U; Brodsky B; Reich R
Arch Toxicol; 2002 Mar; 76(2):119-21. PubMed ID: 11914782
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM).
Babin MC; Ricketts K; Skvorak JP; Gazaway M; Mitcheltree LW; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S141-4. PubMed ID: 11428627
[TBL] [Abstract][Full Text] [Related]
15. Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.
Jain AK; Tewari-Singh N; Inturi S; Kumar D; Orlicky DJ; Agarwal C; White CW; Agarwal R
Toxicol Appl Pharmacol; 2015 May; 285(1):71-8. PubMed ID: 25791923
[TBL] [Abstract][Full Text] [Related]
16. Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism.
Kenar L; Boyunaga H; Serdar M; Karayilanoglu T; Erbil MK
Clin Chem Lab Med; 2006; 44(10):1253-7. PubMed ID: 17032138
[TBL] [Abstract][Full Text] [Related]
17. A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants.
Karacsonyi C; Shanmugam N; Kagan E
Toxicol Lett; 2009 Feb; 185(1):38-44. PubMed ID: 19110046
[TBL] [Abstract][Full Text] [Related]
18. Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cells.
Pino MA; Pietka-Ottlik M; Billack B
Arh Hig Rada Toksikol; 2013; 64(1):77-86. PubMed ID: 23612526
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of O-phenanthroline against mechlorethamine toxicity in the rat liver slice system and in the guinea pig skin.
Wormser U; Nyska A
Arch Toxicol; 1991; 65(8):666-70. PubMed ID: 1747067
[TBL] [Abstract][Full Text] [Related]
20. Role of nicotinamide adenine dinucleotide phosphate oxidase in mediating vesicant-induced interleukin-6 secretion in human airway epithelial cells.
Lee JH; Kagan E
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):713-22. PubMed ID: 24164541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
